Skip to main content

Table 1 Number of dogs per response classification receiving concomitant anti-pruritic medications with RESPIT at D270+

From: Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis

Concomitant anti-pruritic medication Poor
n = 18
Fair
n = 26
Good
n = 39
Excellent
n = 20
None 4 (22%) 6 (23%) 13 (33%) 18 (90%)
Oral glucocorticoid 7 (39%) 10 (38%) 17 (44%) 0 (0%)
Cyclosporine 4 (22%) 7 (27%) 7 (18%) 0 (0%)
Oclacitinib 0 (0%) 0 (0%) 2 (5%) 0 (0%)
Antihistamine 3 (17%) 5 (19%) 1 (3%) 1 (5%)
Topical glucocorticoid, including otic 1 (6%) 1 (4%) 0 (0%) 1 (5%)
  1. 5/103 dogs were receiving two classes of medications